|Access to effective antimicrobials: a worldwide challenge|
R Laxminarayan, P Matsoso, S Pant, C Brower, JA Røttingen, K Klugman, ...
The Lancet 387 (10014), 168-175, 2016
|Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial|
AM Henao-Restrepo, IM Longini, M Egger, NE Dean, WJ Edmunds, ...
The Lancet 386 (9996), 857-866, 2015
|A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?|
JA Røttingen, DW Cameron, GP Garnett
Sexually transmitted diseases 28 (10), 579-597, 2001
|Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial …|
AM Henao-Restrepo, A Camacho, IM Longini, CH Watson, WJ Edmunds, ...
The Lancet 389 (10068), 505-518, 2017
|Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?|
JA Røttingen, S Regmi, M Eide, AJ Young, RF Viergever, C Årdal, ...
The Lancet 382 (9900), 1286-1307, 2013
|Binding of Human Factor VIIa to Tissue Factor Induces Cytosolic Ca2+ Signals in J82 Cells, Transfected COS-1 Cells, Madin-Darby Canine Kidney Cells and in Human Endothelial …|
R John-Arne, T Enden, E Camerer, JG Iversen, H Prydz
Journal of Biological Chemistry 270 (9), 4650-4660, 1995
|Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene|
E Camerer, JA Røttingen, E Gjernes, K Larsen, AH Skartlien, JG Iversen, ...
Journal of Biological Chemistry 274 (45), 32225-32233, 1999
|Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection|
J Sexton, G Garnett, JA Røttingen
Sexually transmitted diseases 32 (6), 351-357, 2005
|Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions?|
T Adam, J Hsu, D De Savigny, JN Lavis, JA Røttingen, S Bennett
Health policy and planning 27 (suppl_4), iv9-iv19, 2012
|Exploring the evidence base for national and regional policy interventions to combat resistance|
OA Dar, R Hasan, J Schlundt, S Harbarth, G Caleo, FK Dar, J Littmann, ...
The Lancet 387 (10015), 285-295, 2016
|Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active|
E Camerer, JA Røttingen, JG Iversen, H Prydz
Journal of Biological Chemistry 271 (46), 29034-29042, 1996
|Guidance for evidence-informed policies about health systems: linking guidance development to policy development|
JN Lavis, JA Røttingen, X Bosch-Capblanch, R Atun, F El-Jardali, L Gilson, ...
PLoS medicine 9 (3), e1001186, 2012
|International cooperation to improve access to and sustain effectiveness of antimicrobials|
C Årdal, K Outterson, SJ Hoffman, A Ghafur, M Sharland, N Ranganathan, ...
The Lancet 387 (10015), 296-307, 2016
|Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries|
M Mendelson, JA Røttingen, U Gopinathan, DH Hamer, H Wertheim, ...
The Lancet 387 (10014), 188-198, 2016
|Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development|
X Bosch-Capblanch, JN Lavis, S Lewin, R Atun, JA Røttingen, D Dröschel, ...
PLoS medicine 9 (3), e1001185, 2012
|Ruled by waves? Intracellular and intercellular calcium signalling.|
J Røttingen, JG Iversen
Acta physiologica scandinavica 169 (3), 203-219, 2000
|Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study|
D Gouglas, TT Le, K Henderson, A Kaloudis, T Danielsen, ...
The Lancet Global Health 6 (12), e1386-e1396, 2018
|Quasi-experimental study designs series—paper 4: uses and value|
T Bärnighausen, P Tugwell, JA Røttingen, I Shemilt, P Rockers, ...
Journal of clinical epidemiology 89, 21-29, 2017
|Trends in health policy and systems research over the past decade: still too little capacity in low-income countries|
T Adam, S Ahmad, M Bigdeli, A Ghaffar, JA Røttingen
PloS one 6 (11), e27263, 2011
|What level of domestic government health expenditure should we aspire to for universal health coverage?|
D McIntyre, F Meheus, JA Røttingen
Health Economics, Policy and Law 12 (2), 125-137, 2017